MedicarePartD.guide

A non-government resource built from CMS public data

Non-statin cholesterol drugs on MedicareBlue Rx Standard (S5743-001)

Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Iowa + 6 more
Premium
$101.00/month
Deductible
$615.00
Change plan

6 of 8 Non-statin cholesterol drugs are covered on this plan. 3 of them require prior authorization.

2 aren't on the formulary (Praluent and icosapent ethyl).

  • ezetimibe
    generic Zetia
    Covered
    $2.84
    Tier 4
  • Repatha
    evolocumab
    Covered · prior auth
    from $383.13
    Tier 3
  • Nexletol
    bempedoic acid
    Covered · prior auth
    $98.13
    Tier 3
  • Nexlizet
    bempedoic acid and ezetimibe
    Covered · prior auth
    $99.12
    Tier 3
  • fenofibrate
    generic Tricor
    Covered
    from $1.70
    Tier 3
  • Vascepa
    icosapent ethyl
    Covered
    from $80.98
    Tier 3
Not on the formulary
Praluent, icosapent ethyl

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list